<DOC>
	<DOC>NCT00608218</DOC>
	<brief_summary>The aim of the study is to evaluate the efficacy of ciclesonide in patients with persistent asthma over 3 months, especially in the cold season. Ciclesonide will be inhaled by a metered-dose inhaler. The study will provide further data on safety and tolerability of ciclesonide.</brief_summary>
	<brief_title>Efficacy of Ciclesonide During the Cold Season in Patients Older Than 12 Years With Persistent Asthma</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Ciclesonide</mesh_term>
	<criteria>Main inclusion criteria: History of persistent bronchial asthma Main exclusion criteria: Hypersensitive to compounds of Alvesco Other criteria as defined in the Summary of Product Characteristics (Fachinformation Chapter 4.3)</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Asthma</keyword>
	<keyword>ciclesonide</keyword>
	<keyword>inhaled steroids</keyword>
	<keyword>Alvesco</keyword>
</DOC>